{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T17:09:32Z","timestamp":1790701772717,"version":"4.1.0"},"reference-count":62,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100007726","name":"Shahid Bahonar University of Kerman","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007726","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2020,11]]},"DOI":"10.1016\/j.neuropharm.2020.107981","type":"journal-article","created":{"date-parts":[[2020,7,31]],"date-time":"2020-07-31T11:13:19Z","timestamp":1596193999000},"page":"107981","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":32,"special_numbering":"C","title":["Activation orexin 1 receptors in the ventrolateral periaqueductal gray matter attenuate nitroglycerin-induced migraine attacks and calcitonin gene related peptide up-regulation in trigeminal nucleus caudalis of rats"],"prefix":"10.1016","volume":"178","author":[{"given":"Razieh","family":"Kooshki","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehdi","family":"Abbasnejad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saeed","family":"Esmaeili-Mahani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maryam","family":"Raoof","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vahid","family":"Sheibani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuropharm.2020.107981_bib1","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1177\/0333102412472071","article-title":"Pearls and pitfalls in experimental in vivo models of migraine: dural trigeminovascular nociception","volume":"33","author":"Akerman","year":"2013","journal-title":"Cephalalgia"},{"key":"10.1016\/j.neuropharm.2020.107981_bib3","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1111\/j.1468-2982.2009.01864.x","article-title":"Sumatriptan alleviates nitroglycerin-induced mechanical and thermal allodynia in mice","volume":"30","author":"Bates","year":"2009","journal-title":"Cephalalgia"},{"key":"10.1016\/j.neuropharm.2020.107981_bib4","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1007\/s12245-010-0248-y","article-title":"Nitroglycerin-induced migraine type headache: bilaterally visible temporal arteries","volume":"3","author":"Bektas","year":"2010","journal-title":"Int. J. Emerg. Med."},{"key":"10.1016\/j.neuropharm.2020.107981_bib5","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1111\/head.12179","article-title":"Calcitonin gene-related peptide (CGRP) and migraine current understanding and state of development","volume":"53","author":"Bigal","year":"2013","journal-title":"Headache J. Head Face Pain"},{"key":"10.1016\/j.neuropharm.2020.107981_bib6","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1111\/head.13281","article-title":"The prevalence and impact of migraine and severe headache in the United States: figures and trends from government health studies","volume":"58","author":"Burch","year":"2018","journal-title":"Headache J. Head Face Pain"},{"key":"10.1016\/j.neuropharm.2020.107981_bib7","doi-asserted-by":"crossref","first-page":"6619","DOI":"10.1523\/JNEUROSCI.0373-15.2015","article-title":"Migraine: multiple processes, complex pathophysiology","volume":"35","author":"Burstein","year":"2015","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2020.107981_bib8","series-title":"Chronic migraine prevalence, disability, and sociodemographic factors: results from the American Migraine Prevalence and Prevention Study.","author":"Buse","year":"2012"},{"key":"10.1016\/j.neuropharm.2020.107981_bib9","doi-asserted-by":"crossref","first-page":"11431","DOI":"10.1523\/JNEUROSCI.3897-16.2017","article-title":"Cortical regulation of nociception of the trigeminal nucleus caudalis","volume":"37","author":"Castro","year":"2017","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2020.107981_bib10","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1177\/0333102414544979","article-title":"Randomized controlled trial of the orexin receptor antagonist filorexant for migraine prophylaxis","volume":"35","author":"Chabi","year":"2015","journal-title":"Cephalalgia"},{"key":"10.1016\/j.neuropharm.2020.107981_bib11","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/s10194-017-0747-9","article-title":"Disrupted functional connectivity of periaqueductal gray subregions in episodic migraine","volume":"18","author":"Chen","year":"2017","journal-title":"J. Headache Pain"},{"key":"10.1016\/j.neuropharm.2020.107981_bib12","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0304-3940(02)00967-9","article-title":"Abnormal brain processing of cutaneous pain in migraine patients during the attack","volume":"333","author":"de Tommaso","year":"2002","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neuropharm.2020.107981_bib13","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.neulet.2004.04.029","article-title":"Nitroglycerin induces migraine headache and central sensitization phenomena in patients with migraine without aura: a study of laser evoked potentials","volume":"363","author":"de Tommaso","year":"2004","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neuropharm.2020.107981_bib14","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1038\/s41582-018-0003-1","article-title":"CGRP as the target of new migraine therapies\u2014successful translation from bench to clinic","volume":"14","author":"Edvinsson","year":"2018","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.neuropharm.2020.107981_bib15","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.1002\/ejp.899","article-title":"Functional interaction between orexin-1 and CB 1 receptors in the periaqueductal gray matter during antinociception induced by chemical stimulation of the lateral hypothalamus in rats","volume":"20","author":"Esmaeili","year":"2016","journal-title":"Eur. J. Pain"},{"key":"10.1016\/j.neuropharm.2020.107981_bib16","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1111\/ejn.13486","article-title":"Chronic ghrelin treatment reduced photophobia and anxiety-like behaviors in nitroglycerin-induced migraine: role of pituitary adenylate cyclase-activating polypeptide","volume":"45","author":"Farajdokht","year":"2017","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.neuropharm.2020.107981_bib17","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.vascn.2015.09.006","article-title":"Utility of different outcome measures for the nitroglycerin model of migraine in mice","volume":"77","author":"Farkas","year":"2016","journal-title":"J. Pharmacol. Toxicol. Methods"},{"key":"10.1016\/j.neuropharm.2020.107981_bib18","first-page":"610","article-title":"Migraine, pathophysiology","volume":"39","author":"Goadsby","year":"2013","journal-title":"J. Cereb. Blood. Flow. Metab"},{"key":"10.1016\/j.neuropharm.2020.107981_bib19","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1152\/physrev.00034.2015","article-title":"Pathophysiology of migraine: a disorder of sensory processing","volume":"vol. 97","author":"Goadsby","year":"2017","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.neuropharm.2020.107981_bib20","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1177\/0333102410379887","article-title":"Temporal profile of vascular changes induced by systemic nitroglycerin in the meningeal and cortical districts","volume":"31","author":"Greco","year":"2011","journal-title":"Cephalalgia"},{"key":"10.1016\/j.neuropharm.2020.107981_bib21","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/S0306-4522(01)00033-1","article-title":"Gene expression and protein distribution of the orexin-1 receptor in the rat brain and spinal cord","volume":"103","author":"Hervieu","year":"2001","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2020.107981_bib22","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1038\/nrneurol.2010.127","article-title":"CGRP and its receptors provide new insights into migraine pathophysiology","volume":"6","author":"Ho","year":"2010","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.neuropharm.2020.107981_bib23","doi-asserted-by":"crossref","first-page":"14600","DOI":"10.1523\/JNEUROSCI.2671-11.2011","article-title":"Activation of orexin 1 receptors in the periaqueductal gray of male rats leads to antinociception via retrograde endocannabinoid (2-arachidonoylglycerol)-induced disinhibition","volume":"31","author":"Ho","year":"2011","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2020.107981_bib24","doi-asserted-by":"crossref","first-page":"2825","DOI":"10.1111\/j.1460-9568.2006.05168.x","article-title":"Modulation of nociceptive dural input to the trigeminal nucleus caudalis via activation of the orexin 1 receptor in the rat","volume":"24","author":"Holland","year":"2006","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.neuropharm.2020.107981_bib25","doi-asserted-by":"crossref","first-page":"29480","DOI":"10.1038\/srep29480","article-title":"The integrative role of orexin\/hypocretin neurons in nociceptive perception and analgesic regulation","volume":"6","author":"Inutsuka","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.neuropharm.2020.107981_bib26","first-page":"1","article-title":"Neurophysiology of orofacial pain","author":"Iwata","year":"2017","journal-title":"Contemp. Oral. Med."},{"key":"10.1016\/j.neuropharm.2020.107981_bib27","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.physbeh.2016.01.031","article-title":"The role of trigeminal nucleus caudalis orexin 1 receptors in orofacial pain transmission and in orofacial pain-induced learning and memory impairment in rats","volume":"157","author":"Kooshki","year":"2016","journal-title":"Physiol. Behav."},{"key":"10.1016\/j.neuropharm.2020.107981_bib28","doi-asserted-by":"crossref","first-page":"174","DOI":"10.3344\/kjp.2018.31.3.174","article-title":"Orexin-A inhibits capsaicin-induced changes in cyclooxygenase-2 and brain-derived neurotrophic factor expression in trigeminal nucleus caudalis of rats","volume":"31","author":"Kooshki","year":"2018","journal-title":"Korean. J. Pain."},{"key":"10.1016\/j.neuropharm.2020.107981_bib29","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1186\/s10194-016-0631-z","article-title":"Valproate ameliorates nitroglycerin-induced migraine in trigeminal nucleus caudalis in rats through inhibition of NF-\u043aB","volume":"17","author":"Li","year":"2016","journal-title":"J. Headache Pain"},{"key":"10.1016\/j.neuropharm.2020.107981_bib30","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/s10194-016-0629-6","article-title":"Increased prevalence of depression and anxiety in patients with migraine and interictal photophobia","volume":"17","author":"Llop","year":"2016","journal-title":"J. Headache Pain"},{"key":"10.1016\/j.neuropharm.2020.107981_bib31","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1002\/ana.22537","article-title":"Altered functional magnetic resonance imaging resting-state connectivity in periaqueductal gray networks in migraine","volume":"70","author":"Mainero","year":"2011","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.neuropharm.2020.107981_bib32","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1002\/cne.1190","article-title":"Differential expression of orexin receptors 1 and 2 in the rat brain","volume":"435","author":"Marcus","year":"2001","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.neuropharm.2020.107981_bib33","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1177\/0333102413486320","article-title":"A chronic animal model of migraine, induced by repeated meningeal nociception, characterized by a behavioral and pharmacological approach","volume":"33","author":"Melo-Carrillo","year":"2013","journal-title":"Cephalalgia"},{"key":"10.1016\/j.neuropharm.2020.107981_bib34","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/0006-8993(89)90461-7","article-title":"Stimulation of the periaqueductal gray matter inhibits nociception at the supraspinal as well as spinal level","volume":"502","author":"Morgan","year":"1989","journal-title":"Brain Res."},{"key":"10.1016\/j.neuropharm.2020.107981_bib35","doi-asserted-by":"crossref","first-page":"S44","DOI":"10.1016\/j.pain.2013.07.021","article-title":"Migraine pathophysiology: anatomy of the trigeminovascular pathway and associated neurological symptoms, cortical spreading depression, sensitization, and modulation of pain","volume":"154","author":"Noseda","year":"2013","journal-title":"PAIN\u00ae"},{"key":"10.1016\/j.neuropharm.2020.107981_bib36","doi-asserted-by":"crossref","first-page":"E5683","DOI":"10.1073\/pnas.1708361114","article-title":"Neural mechanism for hypothalamic-mediated autonomic responses to light during migraine","volume":"114","author":"Noseda","year":"2017","journal-title":"Proc. Natl. Acad. Sci. Unit. States Am."},{"key":"10.1016\/j.neuropharm.2020.107981_bib37","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1111\/j.1468-2982.2004.00845.x","article-title":"CGRP release and c-fos expression within trigeminal nucleus caudalis of the rat following glyceryltrinitrate infusion","volume":"25","author":"Offenhauser","year":"2005","journal-title":"Cephalalgia"},{"key":"10.1016\/j.neuropharm.2020.107981_bib38","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.21055","article-title":"Peripherally administered orexin improves survival of mice with endotoxin shock","volume":"5","author":"Ogawa","year":"2016","journal-title":"Elife"},{"key":"10.1016\/j.neuropharm.2020.107981_bib39","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.pharmthera.2008.08.003","article-title":"The role of nitric oxide (NO) in migraine, tension-type headache and cluster headache","volume":"120","author":"Olesen","year":"2008","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.neuropharm.2020.107981_bib40","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1046\/j.1460-9568.2002.02031.x","article-title":"Effect of systemic nitroglycerin on CGRP and 5-HT afferents to rat caudal spinal trigeminal nucleus and its modulation by estrogen","volume":"15","author":"Pardutz","year":"2002","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.neuropharm.2020.107981_bib41","series-title":"The Rat Brain in Stereotaxic Coordinates in Stereotaxic Coordinates","author":"Paxinos","year":"2007"},{"key":"10.1016\/j.neuropharm.2020.107981_bib42","doi-asserted-by":"crossref","first-page":"9996","DOI":"10.1523\/JNEUROSCI.18-23-09996.1998","article-title":"Neurons containing hypocretin (orexin) project to multiple neuronal systems","volume":"18","author":"Peyron","year":"1998","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2020.107981_bib43","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.npep.2018.12.001","article-title":"Intra-periaqueductal gray matter administration of orexin-A exaggerates pulpitis-induced anxiogenic responses and c-fos expression mainly through the interaction with orexin 1 and cannabinoid 1 receptors in rats","volume":"73","author":"Pourrahimi","year":"2019","journal-title":"Neuropeptides"},{"key":"10.1016\/j.neuropharm.2020.107981_bib44","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.pain.2013.10.004","article-title":"Characterization of a novel model of chronic migraine","volume":"155","author":"Pradhan","year":"2014","journal-title":"PAIN\u00ae"},{"key":"10.1016\/j.neuropharm.2020.107981_bib45","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1007\/s10194-011-0314-8","article-title":"Evidence for an association between migraine and the hypocretin receptor 1 gene","volume":"12","author":"Rainero","year":"2011","journal-title":"J. Headache Pain"},{"key":"10.1016\/j.neuropharm.2020.107981_bib46","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1111\/iej.13007","article-title":"Activation of orexin-1 receptors in the ventrolateral periaqueductal grey matter (vlPAG) modulates pulpal nociception and the induction of substance P in vlPAG and trigeminal nucleus caudalis","volume":"52","author":"Raoof","year":"2019","journal-title":"Int. Endod. J."},{"key":"10.1016\/j.neuropharm.2020.107981_bib47","doi-asserted-by":"crossref","first-page":"3917","DOI":"10.2174\/0929867324666170529072554","article-title":"The orexinergic (hypocretin) system and nociception: an update to supraspinal mechanisms","volume":"25","author":"Roohbakhsh","year":"2018","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.neuropharm.2020.107981_bib48","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/S0092-8674(00)80949-6","article-title":"Orexins and orexin receptors: a family of hypothalamic neuropeptides and G protein-coupled receptors that regulate feeding behavior","volume":"92","author":"Sakurai","year":"1998","journal-title":"Cell"},{"key":"10.1016\/j.neuropharm.2020.107981_bib49","first-page":"2017","article-title":"Divergent modulation of nociception by glutamatergic and GABAergic neuronal subpopulations in the periaqueductal gray","volume":"16","author":"Samineni","year":"2017","journal-title":"Eneuro 4. pii: ENEURO.0129"},{"key":"10.1016\/j.neuropharm.2020.107981_bib50","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1111\/j.1468-2982.2008.01566.x","article-title":"Involvement of corticotrophin-releasing factor and orexin-A in chronic migraine and medication-overuse headache: findings from cerebrospinal fluid","volume":"28","author":"Sarchielli","year":"2008","journal-title":"Cephalalgia"},{"key":"10.1016\/j.neuropharm.2020.107981_bib51","first-page":"99","article-title":"Sensitization and photophobia in migraine","volume":"97","author":"Schain","year":"2017","journal-title":"Handb. Clin. Neurol."},{"key":"10.1016\/j.neuropharm.2020.107981_bib52","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1007\/s11916-014-0467-7","article-title":"Animal models of chronic migraine","volume":"19","author":"Storer","year":"2015","journal-title":"Curr. Pain Headache Rep."},{"key":"10.1016\/j.neuropharm.2020.107981_bib53","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1007\/s13311-017-0602-3","article-title":"Targeted orexin and hypothalamic neuropeptides for migraine","volume":"15","author":"Strother","year":"2018","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.neuropharm.2020.107981_bib54","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/S1674-6384(16)60049-7","article-title":"Effects of zhengtian pills on migraine headache in rats via transient receptor potential vanilloid 1","volume":"8","author":"Sun","year":"2016","journal-title":"Chinese. Herb. Med."},{"key":"10.1016\/j.neuropharm.2020.107981_bib55","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.bbi.2016.06.009","article-title":"Hypocretin\/orexin loss changes the hypothalamic immune response","volume":"57","author":"Tanaka","year":"2016","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.neuropharm.2020.107981_bib56","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.ejphar.2006.01.023","article-title":"Prostaglandins, glutamate and nitric oxide synthase mediate nitroglycerin-induced hyperalgesia in the formalin test","volume":"534","author":"Tassorelli","year":"2006","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2020.107981_bib57","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/S0074-7742(07)82020-4","article-title":"A role for brain cyclooxygenase-2 and prostaglandin- E2 in migraine: effects of nitroglycerin","volume":"82","author":"Tassorelli","year":"2007","journal-title":"Int. Rev. Neurobiol."},{"key":"10.1016\/j.neuropharm.2020.107981_bib58","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1111\/j.1468-1331.1994.tb00053.x","article-title":"A nitric oxide donor (nitroglycerin) triggers genuine migraine attacks","volume":"1","author":"Thomsen","year":"1994","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.neuropharm.2020.107981_bib59","article-title":"The therapeutic impact of new migraine discoveries","author":"V\u00e9csei","year":"2018","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.neuropharm.2020.107981_bib60","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/s10194-019-0963-6","article-title":"Behavioral and cognitive animal models in headache research","volume":"20","author":"Vuralli","year":"2019","journal-title":"J. Headache Pain"},{"key":"10.1016\/j.neuropharm.2020.107981_bib61","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/s40035-017-0095-3","article-title":"Photophobia in neurologic disorders. Transl","volume":"6","author":"Wu","year":"2017","journal-title":"Neurodegeneration"},{"key":"10.1016\/j.neuropharm.2020.107981_bib62","series-title":"Behavioral Study of a Rat Model of Migraine Induced by CGRP","first-page":"134","volume":"vol. 651","author":"Yao","year":"2017"},{"key":"10.1016\/j.neuropharm.2020.107981_bib63","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/s10194-017-0736-z","article-title":"Depression and anxiety behaviour in a rat model of chronic migraine","volume":"18","author":"Zhang","year":"2017","journal-title":"J. Headache Pain"}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390820300472?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390820300472?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T07:04:41Z","timestamp":1758438281000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0028390820300472"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11]]},"references-count":62,"alternative-id":["S0028390820300472"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2020.107981","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2020,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Activation orexin 1 receptors in the ventrolateral periaqueductal gray matter attenuate nitroglycerin-induced migraine attacks and calcitonin gene related peptide up-regulation in trigeminal nucleus caudalis of rats","name":"articletitle","label":"Article Title"},{"value":"Neuropharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuropharm.2020.107981","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"107981"}}